Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.
Bioorg Med Chem. 2012 Feb 1;20(3):1310-8. doi: 10.1016/j.bmc.2011.12.014. Epub 2011 Dec 23.
On the basis of the previous lead N-4-t-butylbenzyl 2-(3-fluoro-4-methylsulfonylaminophenyl) propanamide (3) as a potent TRPV1 antagonist, structure-activity relationships for the B (propanamide part) and C-region (4-t-butylbenzyl part) have been investigated for rTRPV1 in CHO cells. The B-region was modified with dimethyl, cyclopropyl and reverse amides and then the C-region was replaced with 4-substituted phenyl, aryl alkyl and diaryl alkyl derivatives. Among them, compound 50 showed high binding affinity with K(i)=21.5nM, which was twofold more potent than 3 and compound 54 exhibited potent antagonism with K(i(ant))=8.0nM comparable to 3.
在前驱物 N-4-叔丁基苯甲酰基 2-(3-氟-4-甲磺酰氨基苯基)丙酰胺(3)作为一种有效的 TRPV1 拮抗剂的基础上,对 CHO 细胞中的 rTRPV1 的 B(丙酰胺部分)和 C 区(4-叔丁基苄基部分)进行了构效关系研究。B 区用二甲基、环丙基和反向酰胺进行修饰,然后 C 区用 4-取代苯基、芳基烷基和二芳基烷基衍生物取代。其中,化合物 50 表现出与 K(i)=21.5nM 的高结合亲和力,比 3 高两倍,化合物 54 表现出与 K(i(ant))=8.0nM 的有效拮抗作用,与 3 相当。